Shirley Ryan AbilityLab

Academic/HospitalWebsite ↗

Also known as: Dr. Norman Harden | Shirley Ryan AbilityLab | Shirley Ryan Ability Lab | Shirley Ryan AbilityLab and University of Illinois at Chicago (UIC)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 1, 2010

Last known activity

Feb 28, 2025

Timeline

1950s

Jan 1, 1954
Shirley Ryan AbilityLab— Founded

Drugs by trial phase (8 distinct, 7 trials)

Phase 4 (1 own, 0 via acquisition)

milnacipran

Phase 2 (4 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

azacitidine

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT06853015Sponsor investigatorPhase 1/Phase 2Feb 28, 2025
NCT06853015Lead sponsorPhase 1/Phase 2Feb 28, 2025
NCT06853015OfficialPhase 1/Phase 2Feb 28, 2025
NCT06377085Lead sponsorPhase 1May 31, 2024
NCT06377085Sponsor investigatorPhase 1May 31, 2024
NCT06377085OfficialPhase 1May 31, 2024
NCT05447676Lead sponsorEarly Phase 1Jun 30, 2022
NCT05447676Reponsible party - principal investigatorEarly Phase 1Jun 30, 2022
NCT05447676Overall official - principal investigatorEarly Phase 1Jun 30, 2022
NCT05463367CollaboratorPhase 2Jan 1, 2021
NCT02418949Reponsible party - principal investigatorN/ANov 30, 2015
NCT02418949Overall official - principal investigatorN/ANov 30, 2015
NCT02418949Lead sponsorN/ANov 30, 2015
NCT03752749Lead sponsorN/ADec 1, 2014
NCT03752749Reponsible party - principal investigatorN/ADec 1, 2014

Details

Founded: Chicago, IL, US Jan 1, 1954
Last known activity: Feb 28, 2025